Summary
In 428 New Zealand infants given K12 or placebo daily from 6 to 24 months, ear infections did not differ (rate ratio 0.84, 95% confidence interval 0.57 to 1.24), nor did respiratory infections, antibiotic use or health service use. The authors conclude routine use for this purpose is not supported.
Key points
- Doctor-recorded ear infections occurred in 37% of infants given K12 and 39% given placebo (rate ratio 0.84, 95% confidence interval 0.57 to 1.24), not a significant difference.
- Time to first ear infection did not differ (hazard ratio 0.89).
- No significant differences were found for ear infection severity, respiratory infections, antibiotic prescribing or health care use, including among children who took the product more consistently.
- The authors conclude routine use to prevent ear infections in the general infant population is not supported.
- Design: multicenter, double-blind, placebo-controlled trial in New Zealand; 428 infants randomized and given K12 or placebo daily from 6 to 24 months.
- Funding: University of Otago; no competing interests declared.
